Clopidogrel Vs Aspirin Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Nationwide Cohort Study.
- DOI
- 10.1016/j.jacasi.2026.03.041
- Published
- 2026 Aug
- Container
- JACC. Asia
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jacasi.2026.03.041,
title = {Clopidogrel Vs Aspirin Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Nationwide Cohort Study.},
author = {Cho JH and Chan You S and Kim H and Kim M and Jo J and Lee SY and Kim SW and Sibbing D and Gorog DA and Angiolillo DJ and Kubica J and Tantry US and Gurbel PA and Jeong YH},
year = {2026},
journal = {JACC. Asia},
doi = {10.1016/j.jacasi.2026.03.041},
url = {https://doi.org/10.1016/j.jacasi.2026.03.041}
}RIS
TY - JOUR TI - Clopidogrel Vs Aspirin Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Nationwide Cohort Study. AU - Cho JH AU - Chan You S AU - Kim H AU - Kim M AU - Jo J AU - Lee SY AU - Kim SW AU - Sibbing D AU - Gorog DA AU - Angiolillo DJ AU - Kubica J AU - Tantry US AU - Gurbel PA AU - Jeong YH PY - 2026 JO - JACC. Asia DO - 10.1016/j.jacasi.2026.03.041 UR - https://doi.org/10.1016/j.jacasi.2026.03.041 ER -
APA
JH, C., S, C. Y., H, K., M, K., J, J., SY, L., SW, K., D, S., DA, G., DJ, A., J, K., US, T., PA, G., & YH, J. (2026). Clopidogrel Vs Aspirin Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Nationwide Cohort Study.. JACC. Asia. https://doi.org/10.1016/j.jacasi.2026.03.041
Source records
- pubmed · retrieved 2026-09-26T01:46:03.713Z
- europe-pmc · retrieved 2026-09-26T01:46:03.710Z